![Aranesp Hematopoietic Agent Darbepoetin Alfa in Polysorbate Solution 60 mcg / 0.3 mL Subcutaneous or Intravenous Injection Prefilled Syringe 0.3 Ml - Suprememed Aranesp Hematopoietic Agent Darbepoetin Alfa in Polysorbate Solution 60 mcg / 0.3 mL Subcutaneous or Intravenous Injection Prefilled Syringe 0.3 Ml - Suprememed](https://www.suprememed.com/wp-content/uploads/2022/02/aranesphematopoieticagentdarbepoetinamg55513002304-595x595.jpg)
Aranesp Hematopoietic Agent Darbepoetin Alfa in Polysorbate Solution 60 mcg / 0.3 mL Subcutaneous or Intravenous Injection Prefilled Syringe 0.3 Ml - Suprememed
![These highlights do not include all the information needed to use ARANESP safely and effectively. See full prescribing information for ARANESP . ARANESP ® (darbepoetin alfa ) i njection, for intravenous or These highlights do not include all the information needed to use ARANESP safely and effectively. See full prescribing information for ARANESP . ARANESP ® (darbepoetin alfa ) i njection, for intravenous or](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=aranesp-26.jpg&id=643587)
These highlights do not include all the information needed to use ARANESP safely and effectively. See full prescribing information for ARANESP . ARANESP ® (darbepoetin alfa ) i njection, for intravenous or
![Darbepoetin alfa given every 1 or 2 weeks alleviates anaemia associated with cancer chemotherapy | British Journal of Cancer Darbepoetin alfa given every 1 or 2 weeks alleviates anaemia associated with cancer chemotherapy | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.bjc.6600465/MediaObjects/41416_2002_Article_BF6600465_Fig1_HTML.gif)